D S Lindsay, J M Butler, N S Rippey, B L Blagburn
Index: Am. J. Vet. Res. 57(1) , 68-72, (1996)
Full Text: HTML
To examine the efficacies of combinations of 7 sulfonamides and 5 dihydrofolate reductase/thymidylate synthase (DHFR/TS) inhibitors against tachyzoites of Neospora caninum in cultured cells. Mutant tachyzoites that were resistant to pyrimethamine were produced and examined for resistance to other DHFR/TS inhibitors.After 5 days of treatment, a cell culture flask lesion-based assay was used to determine efficacies of combinations of sulfonamides and DHFR/TS inhibitors against N caninum tachyzoites and to evaluate the sensitivity of pyrimethamine-resistant mutants of N caninum to test agents. Cultured cells that were infected with the appropriate strains of N caninum and treated or not treated (controls) with test agents were examined. Mutations were induced by chemical mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine or by selection for growth in permissive concentration of pyrimethamine.Synergism was detected for combinations of pyrimethamine, ormetoprim, trimethoprim, or diaveridine with the sulfonamides. Methotrexate did not have improved efficacy when combined with sulfonamides. Two mutants were produced that were resistant to pyrimethamine. Both mutants were resistant to other DHFR/TS inhibitors. Both mutants remained resistant to pyrimethamine in the absence of continuous exposure to the agent, indicating that the induced resistance was stable. Synergism was detected for combinations of DHFR/TS inhibitors and sulfonamides against these pyrimethamine-resistant mutants.Combinations of suboptimal concentrations of sulfonamides with suboptimal concentrations of DHFR/TS inhibitors results in improved efficacy of the agents in a cell culture assay. Stable resistance to pyrimethamine can be induced in N caninum tachyzoites by use of chemical mutagenesis or by selection.In vitro evidence indicated that combination treatment, using sulfonamides and DHFR/TS inhibitors, may be effective in treating neosporosis.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Diaveridine
CAS:5355-16-8 |
C13H16N4O2 |
[Polarographic determination of diaveridine in biological sa...
1990-01-01 [Acta Pharm. Hung. 60(1) , 23-9, (1990)] |
Inhibitors of folic acid synthesis in the treatment of exper...
1988-01-01 [Antimicrob. Agents Chemother. 32(1) , 96-103, (1988)] |
Determination of residual diaveridine and sulfaquinoxaline i...
1981-08-01 [Chem. Pharm. Bull. 29(8) , 2290-5, (1981)] |
Mutagenicity of the coccidiostat diaveridine in the Salmonel...
1991-10-01 [Mutat. Res. 261(2) , 149-52, (1991)] |
Characterization of in vitro metabolites of trimethoprim and...
2012-09-01 [Biomed. Chromatogr. 26(9) , 1101-8, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved